EPHA2 and head and neck squamous cell carcinoma: In head and neck squamous cell carcinoma (HNSCC), knocking down EphA2 in vitro leads to a reduction in the number of VM channels, and the expression of EphA2 and EMT-related markers such as Twist and Vimentin expression have a positive association [2].